mouse myoblasts Search Results


92
ATCC mouse muscle myoblast g 8 cells
Mouse Muscle Myoblast G 8 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/G-8%3B+Myoblast%3B+Mouse/pmc03807887-55-0-5
Average 92 stars, based on 1 article reviews
mouse muscle myoblast g 8 cells - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
iXCells Biotechnologies murine primary myoblasts
Murine Primary Myoblasts, supplied by iXCells Biotechnologies, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/Mouse+Skeletal+Muscle+Myoblasts/pm39637238-454-0-6
Average 94 stars, based on 1 article reviews
murine primary myoblasts - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

mdck  (ATCC)
97
ATCC mdck
Mdck, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12%3B+Muscle+Myoblast%3B+Mouse/pmc02148212-55-9-10
Average 97 stars, based on 1 article reviews
mdck - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

90
Molecular Biosciences Inc mouse myoblast
Mouse Myoblast, supplied by Molecular Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/mouse+myoblast/pm24854234-252-32-17
Average 90 stars, based on 1 article reviews
mouse myoblast - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science mouse myoblast
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
Mouse Myoblast, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/mouse+myoblast/pmc09439965-235-0-11
Average 90 stars, based on 1 article reviews
mouse myoblast - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Interlab Inc mouse myoblast c2c12 cell line
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
Mouse Myoblast C2c12 Cell Line, supplied by Interlab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/mouse+myoblast+c2c12+cell+line/pm38901103-135-1-9
Average 90 stars, based on 1 article reviews
mouse myoblast c2c12 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pasteur Institute primary mouse myoblasts
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
Primary Mouse Myoblasts, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/primary+mouse+myoblasts/pm15105539-55-0-12
Average 90 stars, based on 1 article reviews
primary mouse myoblasts - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dawley Inc mouse myoblasts
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
Mouse Myoblasts, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/mouse+myoblasts/pm34332029-191-6-31
Average 90 stars, based on 1 article reviews
mouse myoblasts - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank c 2 c 12 mouse myoblasts
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
C 2 C 12 Mouse Myoblasts, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/c+2+c+12+mouse+myoblasts/pmc10164918-25-9-14
Average 90 stars, based on 1 article reviews
c 2 c 12 mouse myoblasts - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Japan SLC inc primary mouse myoblasts
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
Primary Mouse Myoblasts, supplied by Japan SLC inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/primary+mouse+myoblasts/pm35153829-89-0-10
Average 90 stars, based on 1 article reviews
primary mouse myoblasts - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioResource International Inc c 2 c 12 mouse myoblast cells
miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated <t>C2C12</t> cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.
C 2 C 12 Mouse Myoblast Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/c+2+c+12+mouse+myoblast+cells/pmc05082341-49-4-20
Average 90 stars, based on 1 article reviews
c 2 c 12 mouse myoblast cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ScienCell c2c12 myoblasts (a mouse cell line)
Evaluation of the biocompatibility of W-GA in vitro. ( a ) <t>C2C12</t> cells cultured for 7 days in W-GA were evaluated for proliferation and cytotoxicity using live/dead staining. Scale bar = 500 μm. ( b ) Survival rate of C212 cells ( n = 3) is shown as the mean ± standard deviation. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant. ( c ) C2C12 cell proliferation capacity was assessed 24 hours post-treatment using BrdU incorporation. The green signal represents BrdU. Scale bar = 500 μm. ( d ) Quantification of BrdU assay data ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant. ( e ) The cell proliferation ability of C2C12 cells in the W-GA group was further evaluated using a CCK-8 assay. The data are presented as the mean ± standard deviation. NS: Not significant
C2c12 Myoblasts (A Mouse Cell Line), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/c2c12+myoblasts++a+mouse+cell+line+/pmc11757907-52-0-9
Average 90 stars, based on 1 article reviews
c2c12 myoblasts (a mouse cell line) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated C2C12 cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.

Journal: Molecular Therapy. Nucleic Acids

Article Title: miR-539-5p regulates Srebf1 transcription in the skeletal muscle of diabetic mice by targeting DNA methyltransferase 3b

doi: 10.1016/j.omtn.2022.08.013

Figure Lengend Snippet: miR-539-5p inhibits Dnmt3b levels by binding to its 3′ UTR (A) Differentiated C2C12 cells were transfected with the scramble (Scr) or mimics of miR-539-5p, miR-381-3p, or miR-31-5p (1–50 nM). Upon termination of incubation at 48 h, cells were lysed, and 40 μg protein was subjected to western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analyses of the blots are shown below. (B) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h, transcript levels of Dnmt3b were quantified by qRT-PCR. 18S rRNA was taken as the loading control. (C) Cells incubated as in (B) were lysed, and lysates (40 μg) were assessed for DNMT3b protein levels by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the blots is shown below. (D) Depiction of the miR-539-5p binding site in the 3′ UTR of Dnmt3b and the mutations (red) incorporated in the miRNA binding site of the Dnmt3b 3′ UTR (MT) as described under “ .” (E) C2C12 cells were transfected with wild-type (WT) or mutated (MT) 3′ UTR luciferase constructs of Dnmt3b together with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48 h of incubation, cells were harvested, and luciferase activity was measured as described under “ .”. Renilla luciferase activity was normalized to firefly luciferase activity. (F) C2C12 cells were transfected with biotin-labeled Scr or biotin-labeled miR-539-5p mimic (50 nM), and after 48 h, cells were harvested, lysed, and pulled down using streptavidin-linked Dynabeads. Enrichment of Dnmt3b mRNA in biotin-labeled Scr- or miR-539-5p mimic-transfected cells was quantified by real-time PCR using Dnmt3b -specific primers. (G) Primary human skeletal muscle cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. Upon termination of incubation (48 h), DNMT3b expression was assessed by western blot analysis using a DNMT3b antibody. HSC70 was used as a loading control. Densitometric analysis of the same is given alongside the blot. All experiments were performed in at least 3 sets for each group. (H and I) 1 μg RNA from skeletal muscle of chow diet- and HFD-fed mice (n = 5) was reverse transcribed and subjected to qRT-PCR to evaluate the expression of miR-539-5p (H) and Dnmt3b (I). Sno234 and 18S rRNA, respectively, were used as normalization controls. Values are means ± SEM. ∗p < 0.05, ∗∗p < 0.01.

Article Snippet: C2C12, mouse myoblast, and mouse Hepa1-6 cells were obtained from the National Centre for Cell Science (NCCS) (Pune, India) and maintained in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (Gibco, Cambridge, UK) and antibiotic/antimycotic solution (Gibco) at 37°C in 5% CO 2 .

Techniques: Binding Assay, Transfection, Incubation, Western Blot, Control, Quantitative RT-PCR, Luciferase, Construct, Activity Assay, Labeling, Real-time Polymerase Chain Reaction, Expressing, Reverse Transcription

miR-539-5p regulates Srebf1 transcript levels by inhibiting Dnmt3b expression and altering CpG methylation on the Srebf1 gene in C2C12 cells (A) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48-h incubation, cells were harvested, and expression of transcript levels of Prkab2 , Srebf1 , and Irs1 (as described under “ ”) was evaluated using qRT-PCR. 18S rRNA was used as the loading control. (B) Schematic of CpG islands across the Srebf1 gene in mice. Each CpG site was randomly split into three regions, and primers were designed to amplify these regions within each CpG island using primers sets (P1, P2, and P3) as shown. (C) Differentiated C2C12 cells were transfected as in (A) with Scr or the miRNA mimic, and upon termination of incubation, genomic DNA was isolated, sheared, and immunoprecipitated (2 μg) with a 5-methylcytosine antibody (2 μg) or non-immune rabbit IgG (2 μg) and incubated overnight at 4°C. Methylation-enriched CpG regions within the Srebf1 gene were quantified by real-time PCR using CpG region-specific primers. (D) Genomic DNA isolated from skeletal muscle of normal db/+ and diabetic db/db mice was sheared, and the methylation status within Srebf1 was quantified by real-time PCR as described in (C). Differentiated C2C12 cells were transfected with the Scr or Dnmt3b siRNA (50–100 nM), and after 48 h, cells were harvested, and DNMT3b expression was quantified at the transcript (E) and protein (F) levels. 18S rRNA and HSC70 were used as normalization controls, respectively. (G) Differentiated C2C12 cells transfected with the Scr or Dnmt3b siRNA (50–100 nM) were harvested, and 1 μg RNA was reverse transcribed to evaluate the transcript levels of Srebf1 by qRT-PCR. 18S rRNA was used as the normalization control. Values are means±SEM of at least three independent experiments. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. ns, non-significant.

Journal: Molecular Therapy. Nucleic Acids

Article Title: miR-539-5p regulates Srebf1 transcription in the skeletal muscle of diabetic mice by targeting DNA methyltransferase 3b

doi: 10.1016/j.omtn.2022.08.013

Figure Lengend Snippet: miR-539-5p regulates Srebf1 transcript levels by inhibiting Dnmt3b expression and altering CpG methylation on the Srebf1 gene in C2C12 cells (A) Differentiated C2C12 cells were transfected with the Scr or the miR-539-5p mimic with or without its inhibitor. After 48-h incubation, cells were harvested, and expression of transcript levels of Prkab2 , Srebf1 , and Irs1 (as described under “ ”) was evaluated using qRT-PCR. 18S rRNA was used as the loading control. (B) Schematic of CpG islands across the Srebf1 gene in mice. Each CpG site was randomly split into three regions, and primers were designed to amplify these regions within each CpG island using primers sets (P1, P2, and P3) as shown. (C) Differentiated C2C12 cells were transfected as in (A) with Scr or the miRNA mimic, and upon termination of incubation, genomic DNA was isolated, sheared, and immunoprecipitated (2 μg) with a 5-methylcytosine antibody (2 μg) or non-immune rabbit IgG (2 μg) and incubated overnight at 4°C. Methylation-enriched CpG regions within the Srebf1 gene were quantified by real-time PCR using CpG region-specific primers. (D) Genomic DNA isolated from skeletal muscle of normal db/+ and diabetic db/db mice was sheared, and the methylation status within Srebf1 was quantified by real-time PCR as described in (C). Differentiated C2C12 cells were transfected with the Scr or Dnmt3b siRNA (50–100 nM), and after 48 h, cells were harvested, and DNMT3b expression was quantified at the transcript (E) and protein (F) levels. 18S rRNA and HSC70 were used as normalization controls, respectively. (G) Differentiated C2C12 cells transfected with the Scr or Dnmt3b siRNA (50–100 nM) were harvested, and 1 μg RNA was reverse transcribed to evaluate the transcript levels of Srebf1 by qRT-PCR. 18S rRNA was used as the normalization control. Values are means±SEM of at least three independent experiments. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. ns, non-significant.

Article Snippet: C2C12, mouse myoblast, and mouse Hepa1-6 cells were obtained from the National Centre for Cell Science (NCCS) (Pune, India) and maintained in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (Gibco, Cambridge, UK) and antibiotic/antimycotic solution (Gibco) at 37°C in 5% CO 2 .

Techniques: Expressing, CpG Methylation Assay, Transfection, Incubation, Quantitative RT-PCR, Control, Isolation, Immunoprecipitation, Methylation, Real-time Polymerase Chain Reaction, Reverse Transcription

Dnmt3b inhibition rescues the miR-539-5p inhibitor-induced decrease in Srebf1 levels in C2C12 cells (A and B) C2C12 cells were incubated in the presence of a DNMT3b inhibitor (nanaomycin A [NA]) at doses of 1, 5, and 10 μM. Control cells were incubated in the presence of DMSO. After 48 h, DNMT1, DNMT3a, and DNMT3b levels were evaluated by qRT-PCR (A) and western blot (B). 18S rRNA and HSC70, respectively, were used as the loading controls. D, DMSO. (C) Cells incubated as in (A) were assayed for activity of DNMT as described under “ .” Data were normalized to the total protein content. (D) Total RNA was isolated from cells incubated as in (A), and the transcript levels of Srebf1 were quantified using specific primers. 18S rRNA was used as the normalization control. (E–G) C2C12 cells were transfected with the Scr or miR-539-5p inhibitor (25–50 nM), and after 48 h, the status of DNMT3b (E and F) and Srebf1 (G) were evaluated by qRT-PCR and western blot analysis. HSC70 and 18S rRNA were taken as the normalizing controls for western blot and qRT-PCR experiments, respectively. (H and I) C2C12 cells were transfected with the Scr or miRNA-539-5p alone (50 nM) or along with Dnmt3b siRNA (100 nM), and after 48 h, Dnmt3b (H) and Srebf1 (I) transcript levels were evaluated by qRT-PCR. 18S rRNA was taken as the endogenous control. (J) C2C12 cells were transfected with the empty vector or the Dnmt3b overexpression vector (1 μg) together with the Scr or miR-539-5p (50 nM); after 48 h, total RNA was isolated, and the transcript levels of Srebf1 were evaluated by qRT-PCR. 18S rRNA was used as the endogenous control. All experiments were performed at least three times for each group, and values are reported as means ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Journal: Molecular Therapy. Nucleic Acids

Article Title: miR-539-5p regulates Srebf1 transcription in the skeletal muscle of diabetic mice by targeting DNA methyltransferase 3b

doi: 10.1016/j.omtn.2022.08.013

Figure Lengend Snippet: Dnmt3b inhibition rescues the miR-539-5p inhibitor-induced decrease in Srebf1 levels in C2C12 cells (A and B) C2C12 cells were incubated in the presence of a DNMT3b inhibitor (nanaomycin A [NA]) at doses of 1, 5, and 10 μM. Control cells were incubated in the presence of DMSO. After 48 h, DNMT1, DNMT3a, and DNMT3b levels were evaluated by qRT-PCR (A) and western blot (B). 18S rRNA and HSC70, respectively, were used as the loading controls. D, DMSO. (C) Cells incubated as in (A) were assayed for activity of DNMT as described under “ .” Data were normalized to the total protein content. (D) Total RNA was isolated from cells incubated as in (A), and the transcript levels of Srebf1 were quantified using specific primers. 18S rRNA was used as the normalization control. (E–G) C2C12 cells were transfected with the Scr or miR-539-5p inhibitor (25–50 nM), and after 48 h, the status of DNMT3b (E and F) and Srebf1 (G) were evaluated by qRT-PCR and western blot analysis. HSC70 and 18S rRNA were taken as the normalizing controls for western blot and qRT-PCR experiments, respectively. (H and I) C2C12 cells were transfected with the Scr or miRNA-539-5p alone (50 nM) or along with Dnmt3b siRNA (100 nM), and after 48 h, Dnmt3b (H) and Srebf1 (I) transcript levels were evaluated by qRT-PCR. 18S rRNA was taken as the endogenous control. (J) C2C12 cells were transfected with the empty vector or the Dnmt3b overexpression vector (1 μg) together with the Scr or miR-539-5p (50 nM); after 48 h, total RNA was isolated, and the transcript levels of Srebf1 were evaluated by qRT-PCR. 18S rRNA was used as the endogenous control. All experiments were performed at least three times for each group, and values are reported as means ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Article Snippet: C2C12, mouse myoblast, and mouse Hepa1-6 cells were obtained from the National Centre for Cell Science (NCCS) (Pune, India) and maintained in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (Gibco, Cambridge, UK) and antibiotic/antimycotic solution (Gibco) at 37°C in 5% CO 2 .

Techniques: Inhibition, Incubation, Control, Quantitative RT-PCR, Western Blot, Activity Assay, Isolation, Transfection, Plasmid Preparation, Over Expression

Evaluation of the biocompatibility of W-GA in vitro. ( a ) C2C12 cells cultured for 7 days in W-GA were evaluated for proliferation and cytotoxicity using live/dead staining. Scale bar = 500 μm. ( b ) Survival rate of C212 cells ( n = 3) is shown as the mean ± standard deviation. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant. ( c ) C2C12 cell proliferation capacity was assessed 24 hours post-treatment using BrdU incorporation. The green signal represents BrdU. Scale bar = 500 μm. ( d ) Quantification of BrdU assay data ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant. ( e ) The cell proliferation ability of C2C12 cells in the W-GA group was further evaluated using a CCK-8 assay. The data are presented as the mean ± standard deviation. NS: Not significant

Journal: Burns & Trauma

Article Title: Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes

doi: 10.1093/burnst/tkae059

Figure Lengend Snippet: Evaluation of the biocompatibility of W-GA in vitro. ( a ) C2C12 cells cultured for 7 days in W-GA were evaluated for proliferation and cytotoxicity using live/dead staining. Scale bar = 500 μm. ( b ) Survival rate of C212 cells ( n = 3) is shown as the mean ± standard deviation. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant. ( c ) C2C12 cell proliferation capacity was assessed 24 hours post-treatment using BrdU incorporation. The green signal represents BrdU. Scale bar = 500 μm. ( d ) Quantification of BrdU assay data ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant. ( e ) The cell proliferation ability of C2C12 cells in the W-GA group was further evaluated using a CCK-8 assay. The data are presented as the mean ± standard deviation. NS: Not significant

Article Snippet: C2C12 myoblasts (a mouse cell line) were obtained from ScienCell Research Laboratories and cultured in Dulbecco's modified Eagle’s medium (DMEM; containing 25 mM glucose; Gibco, USA), which included 10% fetal bovine serum (Gibco, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, USA), in a humidified atmosphere at 37°C and 5% CO 2 .

Techniques: In Vitro, Cell Culture, Staining, Standard Deviation, BrdU Incorporation Assay, BrdU Staining, CCK-8 Assay

Antiapoptotic, antioxidative, and myogenic differentiation-promoting effects of W-GA. ( a ) Flow cytometry profiles showing the abundance of total C2C12 cells under various treatment conditions, along with apoptosis events in C2C12 cells under different therapeutic interventions. ( b ) Quantification of flow cytometry data for apoptotic cells ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * * p < 0.01. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. ( c ) Flow cytometry profiles showing the production of ROS in C2C12 cells under different treatment conditions. ( d ) Quantification of flow cytometry data for ROS production ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * p < 0.05. ( e ) Representative immunofluorescence image illustrating MYHC and MyoD protein expression in C2C12 myoblasts. Scale bar = 100 μm. ( f ) Quantitative analysis and intergroup comparison of myotube diameters ( n = 3). The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant, * p < 0.05, * * p < 0.01

Journal: Burns & Trauma

Article Title: Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes

doi: 10.1093/burnst/tkae059

Figure Lengend Snippet: Antiapoptotic, antioxidative, and myogenic differentiation-promoting effects of W-GA. ( a ) Flow cytometry profiles showing the abundance of total C2C12 cells under various treatment conditions, along with apoptosis events in C2C12 cells under different therapeutic interventions. ( b ) Quantification of flow cytometry data for apoptotic cells ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * * p < 0.01. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. ( c ) Flow cytometry profiles showing the production of ROS in C2C12 cells under different treatment conditions. ( d ) Quantification of flow cytometry data for ROS production ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * p < 0.05. ( e ) Representative immunofluorescence image illustrating MYHC and MyoD protein expression in C2C12 myoblasts. Scale bar = 100 μm. ( f ) Quantitative analysis and intergroup comparison of myotube diameters ( n = 3). The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant, * p < 0.05, * * p < 0.01

Article Snippet: C2C12 myoblasts (a mouse cell line) were obtained from ScienCell Research Laboratories and cultured in Dulbecco's modified Eagle’s medium (DMEM; containing 25 mM glucose; Gibco, USA), which included 10% fetal bovine serum (Gibco, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, USA), in a humidified atmosphere at 37°C and 5% CO 2 .

Techniques: Flow Cytometry, Standard Deviation, Immunofluorescence, Expressing, Comparison